Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial

Autor: Tesfaye, Solomon *, Sloan, Gordon, Petrie, Jennifer, White, David, Bradburn, Mike, Julious, Steven, Rajbhandari, Satyan, Sharma, Sanjeev, Rayman, Gerry, Gouni, Ravikanth, Alam, Uazman, Cooper, Cindy, Loban, Amanda, Sutherland, Katie, Glover, Rachel, Waterhouse, Simon, Turton, Emily, Horspool, Michelle, Gandhi, Rajiv, Maguire, Deirdre, Jude, Edward B, Ahmed, Syed H, Vas, Prashanth, Hariman, Christian, McDougall, Claire, Devers, Marion, Tsatlidis, Vasileios, Johnson, Martin, Rice, Andrew S C, Bouhassira, Didier, Bennett, David L, Selvarajah, Dinesh
Zdroj: In The Lancet 27 August-2 September 2022 400(10353):680-690
Databáze: ScienceDirect